| Aug 2, 2026 | WPS Government Health Administrators | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)LCD · WPS-J5-L40195 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Transurethral Waterjet Ablation of the ProstateLCD · WPS-J5-L40194 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Transurethral Waterjet Ablation of the ProstateLCD · WPS-J5-L40194 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)LCD · WPS-J5-L40193 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)LCD · WPS-J5-L40193 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)LCD · WPS-J5-L40192 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)LCD · WPS-J5-L40192 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative NeoplasmsLCD · WPS-J5-L40022 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative NeoplasmsLCD · WPS-J5-L40022 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLCD · WPS-J5-L39989 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLCD · WPS-J5-L39989 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin AmyloidosisLCD · WPS-J5-L39987 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin AmyloidosisLCD · WPS-J5-L39987 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)LCD · WPS-J5-L39913 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)LCD · WPS-J5-L39913 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Total Joint ArthroplastyLCD · WPS-J5-L39911 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Total Joint ArthroplastyLCD · WPS-J5-L39911 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Botulinum Toxin InjectionsLCD · WPS-J5-L39909 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Botulinum Toxin InjectionsLCD · WPS-J5-L39909 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Botulinum Toxin InjectionsLCD · WPS-J5-L39908 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Botulinum Toxin InjectionsLCD · WPS-J5-L39908 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Micro-Invasive Glaucoma Surgery (MIGS)LCD · WPS-J5-L39907 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Micro-Invasive Glaucoma Surgery (MIGS)LCD · WPS-J5-L39907 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Cataract SurgeryLCD · WPS-J5-L39905 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Cataract SurgeryLCD · WPS-J5-L39905 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Cervical FusionLCD · WPS-J5-L39788 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Cervical FusionLCD · WPS-J5-L39788 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesLCD · WPS-J5-L39720 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesLCD · WPS-J5-L39720 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Trigger Point InjectionsLCD · WPS-J5-L39713 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Trigger Point InjectionsLCD · WPS-J5-L39713 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyLCD · WPS-J5-L39711 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyLCD · WPS-J5-L39711 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate CancersLCD · WPS-J5-L39709 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate CancersLCD · WPS-J5-L39709 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-WoundLCD · WPS-J5-L39624 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-WoundLCD · WPS-J5-L39624 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell CarcinomaLCD · WPS-J5-L39614 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell CarcinomaLCD · WPS-J5-L39614 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Intraarticular Knee Injections of HyaluronanLCD · WPS-J5-L39529 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Intraarticular Knee Injections of HyaluronanLCD · WPS-J5-L39529 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisLCD · WPS-J5-L39481 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisLCD · WPS-J5-L39481 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLCD · WPS-J5-L39479 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLCD · WPS-J5-L39479 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell OriginLCD · WPS-J5-L39477 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell OriginLCD · WPS-J5-L39477 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Sacroiliac Joint Injections and ProceduresLCD · WPS-J5-L39475 | Codes changed |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | Sacroiliac Joint Injections and ProceduresLCD · WPS-J5-L39475 | New policy |
|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLCD · WPS-J5-L39356 | Codes changed |
|---|